FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080434471> ?p ?o ?g. }

• W2080434471 endingPage "5406" @default.
• W2080434471 startingPage "5401" @default.
• W2080434471 abstract "This study was performed to compare four Clostridium perfringens recombinant proteins as vaccine candidates using the Montanide™ ISA 71 VG adjuvant in an experimental model of necrotic enteritis. Broiler chickens were immunized subcutaneously with purified clostridial recombinant NetB toxin, pyruvate: ferredoxin oxidoreductase (PFO), α-toxin, or elongation factor-Tu (EF-Tu), or with vehicle control, in conjunction with ISA 71 VG, and intestinal lesion scores, body weight gains, NetB toxin and PFO antibody levels, and proinflammatory cytokine and chemokine levels were measured as outcomes of protection following oral co-infection with C. perfringens and Eimeria maxima. Birds immunized with all recombinant proteins plus ISA 71 VG showed significantly reduced gut lesions compared with the ISA 71 VG-only group. Birds immunized with NetB toxin or PFO plus ISA 71 VG exhibited significantly increased body weight gains compared with the ISA 71 VG alone group. Greater NetB toxin antibody titers were observed in the NetB/ISA 71 VG group, and greater PFO antibody titers were evident in the PFO/ISA 71 VG group, each compared with the other three vaccine/adjuvant groups. Finally, decreased levels of gene transcripts encoding interleukin-8, tumor necrosis factor superfamily 15, and LPS-induced TNF-α factor were observed in the intestinal lymphocytes of chickens immunized with NetB toxin, PFO, α-toxin, and/or EF-Tu in the presence of ISA 71 VG compared with ISA 71 VG alone. All parameters evaluated were equal in co-infected chickens given ISA 71 VG alone compared with infected/adjuvant-free birds, indicating that the adjuvant itself did not have a disease protective effect. These results suggest that vaccination with clostridial recombinant proteins, particularly NetB toxin or PFO, in combination with ISA 71 VG enhances protective immunity against experimental necrotic enteritis in broiler chickens." @default.
• W2080434471 created "2016-06-24" @default.
• W2080434471 creator A5005593666 @default.
• W2080434471 creator A5010025414 @default.
• W2080434471 creator A5010232095 @default.
• W2080434471 creator A5018052057 @default.
• W2080434471 creator A5020157148 @default.
• W2080434471 creator A5020772215 @default.
• W2080434471 creator A5035053381 @default.
• W2080434471 creator A5041148840 @default.
• W2080434471 creator A5055934572 @default.
• W2080434471 creator A5057177890 @default.
• W2080434471 creator A5063648180 @default.
• W2080434471 creator A5085689759 @default.
• W2080434471 creator A5090689906 @default.
• W2080434471 date "2012-08-01" @default.
• W2080434471 modified "2023-09-23" @default.
• W2080434471 title "Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide™ ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens" @default.
• W2080434471 cites W1449114343 @default.
• W2080434471 cites W1964610623 @default.
• W2080434471 cites W1969256725 @default.
• W2080434471 cites W1987420509 @default.
• W2080434471 cites W1990619325 @default.
• W2080434471 cites W1992948287 @default.
• W2080434471 cites W1994371693 @default.
• W2080434471 cites W1999225385 @default.
• W2080434471 cites W2001474512 @default.
• W2080434471 cites W2012749673 @default.
• W2080434471 cites W2034038126 @default.
• W2080434471 cites W2034965138 @default.
• W2080434471 cites W2037519719 @default.
• W2080434471 cites W2041528883 @default.
• W2080434471 cites W2077385052 @default.
• W2080434471 cites W2077844467 @default.
• W2080434471 cites W2087560843 @default.
• W2080434471 cites W2091722523 @default.
• W2080434471 cites W2098167705 @default.
• W2080434471 cites W2100706861 @default.
• W2080434471 cites W2117608098 @default.
• W2080434471 cites W2141178521 @default.
• W2080434471 cites W2141998772 @default.
• W2080434471 cites W2333146760 @default.
• W2080434471 doi "https://doi.org/10.1016/j.vaccine.2012.06.007" @default.
• W2080434471 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22713719" @default.
• W2080434471 hasPublicationYear "2012" @default.
• W2080434471 type Work @default.
• W2080434471 sameAs 2080434471 @default.
• W2080434471 citedByCount "74" @default.
• W2080434471 countsByYear W20804344712013 @default.
• W2080434471 countsByYear W20804344712014 @default.
• W2080434471 countsByYear W20804344712015 @default.
• W2080434471 countsByYear W20804344712016 @default.
• W2080434471 countsByYear W20804344712017 @default.
• W2080434471 countsByYear W20804344712018 @default.
• W2080434471 countsByYear W20804344712019 @default.
• W2080434471 countsByYear W20804344712020 @default.
• W2080434471 countsByYear W20804344712021 @default.
• W2080434471 countsByYear W20804344712022 @default.
• W2080434471 countsByYear W20804344712023 @default.
• W2080434471 crossrefType "journal-article" @default.
• W2080434471 hasAuthorship W2080434471A5005593666 @default.
• W2080434471 hasAuthorship W2080434471A5010025414 @default.
• W2080434471 hasAuthorship W2080434471A5010232095 @default.
• W2080434471 hasAuthorship W2080434471A5018052057 @default.
• W2080434471 hasAuthorship W2080434471A5020157148 @default.
• W2080434471 hasAuthorship W2080434471A5020772215 @default.
• W2080434471 hasAuthorship W2080434471A5035053381 @default.
• W2080434471 hasAuthorship W2080434471A5041148840 @default.
• W2080434471 hasAuthorship W2080434471A5055934572 @default.
• W2080434471 hasAuthorship W2080434471A5057177890 @default.
• W2080434471 hasAuthorship W2080434471A5063648180 @default.
• W2080434471 hasAuthorship W2080434471A5085689759 @default.
• W2080434471 hasAuthorship W2080434471A5090689906 @default.
• W2080434471 hasConcept C104317684 @default.
• W2080434471 hasConcept C159047783 @default.
• W2080434471 hasConcept C159654299 @default.
• W2080434471 hasConcept C203014093 @default.
• W2080434471 hasConcept C22889606 @default.
• W2080434471 hasConcept C2777367657 @default.
• W2080434471 hasConcept C2777863537 @default.
• W2080434471 hasConcept C2777976947 @default.
• W2080434471 hasConcept C2778773781 @default.
• W2080434471 hasConcept C2779116991 @default.
• W2080434471 hasConcept C2780868878 @default.
• W2080434471 hasConcept C32611913 @default.
• W2080434471 hasConcept C40767141 @default.
• W2080434471 hasConcept C523546767 @default.
• W2080434471 hasConcept C54355233 @default.
• W2080434471 hasConcept C55493867 @default.
• W2080434471 hasConcept C86803240 @default.
• W2080434471 hasConcept C89423630 @default.
• W2080434471 hasConceptScore W2080434471C104317684 @default.
• W2080434471 hasConceptScore W2080434471C159047783 @default.
• W2080434471 hasConceptScore W2080434471C159654299 @default.
• W2080434471 hasConceptScore W2080434471C203014093 @default.
• W2080434471 hasConceptScore W2080434471C22889606 @default.
• W2080434471 hasConceptScore W2080434471C2777367657 @default.
• W2080434471 hasConceptScore W2080434471C2777863537 @default.

• next